Physiologically Based Synthetic Models of Hepatic Disposition
Current physiologically based pharmacokinetic (PBPK) models are inductive. We present an additional, different approach that is based on the synthetic rather than the inductive approach to modeling and simulation. It relies on object-oriented programming. A model of the referent system in its experimental context is synthesized by assembling objects that represent components such as molecules, cells, aspects of tissue architecture, catheters, etc. The single pass perfused rat liver has been well described in evaluating hepatic drug pharmacokinetics (PK) and is the system on which we focus. In silico experiments begin with administration of objects representing actual compounds. Data are collected in a manner analogous to that in the referent PK experiments. The synthetic modeling method allows for recognition and representation of discrete event and discrete time processes, as well as heterogeneity in organization, function, and spatial effects. An application is developed for sucrose and antipyrine, administered separately and together. PBPK modeling has made extensive progress in characterizing abstracted PK properties but this has also been its limitation. Now, other important questions and possible extensions emerge. How are these PK properties and the observed behaviors generated? The inherent heuristic limitations of traditional models have hindered getting meaningful, detailed answers to such questions. Synthetic models of the type described here are specifically intended to help answer such questions. Analogous to wet-lab experimental models, they retain their applicability even when broken apart into sub-components. Having and applying this new class of models along with traditional PK modeling methods is expected to increase the productivity of pharmaceutical research at all levels that make use of modeling and simulation.
Keywordsphysiologically based liver modeling (modelling) simulation discrete event agent-based
in silico liver(s)
- N1, N2,...
a set of experiments that explores sinusoidal network arrangement
physiologically based pharmacokinetic
properties and characteristics
- S1, S2,...
a set of experiments that explores spatial relationships within and between sinusoids
- SA and SB
two classes of SS
Unable to display preview. Download preview PDF.
- 2.Hung D.Y., Chang P., Weiss M., Roberts M.S. (2001) Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. J. Pharmacol. Exper. Therap. 297:780–89Google Scholar
- 4.M. Rowland, L. Balant, and C. Peck. Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown DC, May 29–30, 2002). AAPS PharmSci. 6: article 6. DOI: 10.1208/ps060106 (2004).Google Scholar
- 7.Corley R.A., Mast T.J., Carney E.W., Rogers J.M., Daston G.P. (2003) Evaluation of physiologically based models of pregnancy and lactation for their application in children’s health risk assessments. Crit. Rev. Toxicol. 34(2):137–211Google Scholar
- 10.Zeigler B.P., Praehofer H., Kim T.G. (2000) Theory of Modeling and Simulation: Discrete Event and Continuous Complex Dynamic Systems. Academic Press, California, pp. 3–36, 75–85, 99–104, 137–147.Google Scholar
- 11.Steels L., Brooks R. (eds). (1995) The Artificial Life Route to Artificial Intelligence. Lawrence Earlbaum Associates Inc., New Jersey, pp. 83–121Google Scholar
- 12.Czarnecki K., Eisenecker U. (2000) Generative Programming: Methods, Tools, and Application. Addison-Wesley, New York, pp. 10, 251–254.Google Scholar
- 13.G. E. Ropella, C. A. Hunt, and D. A. Nag. Using heuristic models to bridge the gap between analytic and experimental models in biology. 2005 Spring Simulation Multiconference, The Society for Modeling and Simulation International, San Diego, CA, April 2–8, 2005.Google Scholar
- 14.G. E. Ropella, C. A. Hunt, and S. Sheikh-Bahaei. Methodological considerations of heuristic modeling of biological systems. The 9th World Multi-Conference on Systemics, Cybernetics and Informatics, Orlando, FL, July 10–13, 2005.Google Scholar
- 19.Gumucio J.J., Miller D.L. (1982) Zonal hepatic function: solute-hepatocyte interactions within the liver acinus. Prog. Liver. Diseases. 7:17–30Google Scholar
- 23.Koo A., Liang I.Y., Cheng K.K. (1975) The terminal hepatic microcirculation in the rat. Quart. J. Exp. Physiol. Cogn. Med. 60:261–266Google Scholar
- 28.S. Sheikh-Bahaei, G. E. P. Ropella, and C. A. Hunt. Agent-based simulation of in vitro hepatic drug metabolism: in silico hepatic intrinsic clearance. 2005 Spring Multiconference, The Society for Modeling and Simulation International, San Diego, CA, April 2–8, 2005.Google Scholar
- 29.S. Sheikh-Bahaei, G. E. P. Ropella, and C. A. Hunt. In silico hepatocyte: agent-based modeling of the biliary excretion of drugs. 2006 Spring Simulation Multiconference, The Society for Modeling and Simulation International, Huntsville, AL, April 2–6, 2006.Google Scholar
- 31.D. A. Nag, G. E. P. Ropella, and C. A. Hunt. Similarity measures and validation in automated modeling. Huntsville Simulation Conference, Huntsville, AL, October 25–27, 2005.Google Scholar
- 33.Pang K.S., Lee W.-F., Cherry W.F., Yuen V., Accaputo J., Fayz S., Schwab A.J., Goresky C.A. (1988) Effects of perfusate flow rate on measured blood volume, Disse space, intracellular water space, and drug extraction in the perfused rat liver preparation: characterization by the multiple indicator dilution technique. J. Pharmacokinet. Biopharm. 16:595–632PubMedCrossRefGoogle Scholar
- 36.Food and Drug Administration. Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products [online], < http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html > (2004).Google Scholar
- 37.Hunt C.A., Ropella G.E.P., Roberts M.S., Yan L. (2005) Biomimetic in silico devices. Lecture Notes in Bioinformatics 3082:35–43Google Scholar